Please assess the completion status of the following clinical trial:

Trial Title: An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Plaque psoriasis for at least 6 months~* Moderate to severe disease~* Candidate for phototherapy or systemic therapy~Exclusion Criteria:~* Other forms of psoriasis~* History of recent infection~* Prior exposure to BMS-986165~Other inclusion/exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm A:BMS-986165 oral administration (Type: EXPERIMENTAL): None
- Arm B: Placebo oral administration (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).